Phospholipid arrays on porous polymer coatings generated by micro-contact spotting
Source abstract
Abstract
Nanoporous poly(2-hydroxyethyl methacrylate-co-ethylene dimethacrylate) (HEMA-EDMA) is used as a 3D mesh for spotting lipid arrays. Its porous structure is an ideal matrix for lipid ink to infiltrate, resulting in higher fluorescent signal intensity as compared to similar arrays on strictly 2D substrates like glass. The embedded lipid arrays show high stability against washing steps, while still being accessible for protein and antibody binding. To characterize binding to polymer-embedded lipids we have applied Streptavidin as well as biologically important biotinylated androgen receptor binding onto 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (Biotinyl Cap PE) and anti-DNP IgE recognition of 2,4-dinitrophenyl[1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]hexanoyl] (DNP)] antigen. This approach adds lipid arrays to the range of HEMA polymer applications and makes this solid substrate a very attractive platform for a variety of bio-applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Biosensing Techniques and Applications · Nanofabrication and Lithography Techniques · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. 10.1126/science.199043810.1126/science.1990438 ↗
2. 10.1080/0738855060097835810.1080/07388550600978358 ↗
3. 10.1021/cr068446710.1021/cr0684467 ↗
4. 10.1002/anie.20090148010.1002/anie.200901480 ↗
5. 10.1021/la400570h10.1021/la400570h ↗
6. 10.1016/S1470-2045(09)70229-310.1016/S1470-2045(09)70229-3 ↗
7. 10.1016/j.jneuroim.2011.08.00210.1016/j.jneuroim.2011.08.002 ↗
8. 10.1038/nm134410.1038/nm1344 ↗
9. 10.3762/bjnano.4.4410.3762/bjnano.4.44 ↗
10. 10.1002/admi.20150046910.1002/admi.201500469 ↗
11. 10.1002/smll.20060043110.1002/smll.200600431 ↗
12. 10.1039/C5NR04352B10.1039/C5NR04352B ↗
13. 10.1023/B:BMMD.0000031748.13353.1010.1023/B:BMMD.0000031748.13353.10 ↗
14. 10.1039/C6RA12194B10.1039/C6RA12194B ↗
15. 10.1002/admi.20130012910.1002/admi.201300129 ↗
16. 10.1073/pnas.88.18.816910.1073/pnas.88.18.8169 ↗
17. 10.1002/smll.20110169410.1002/smll.201101694 ↗
18. 10.1621/nrs.0300110.1621/nrs.03001 ↗
19. 10.3978/j.issn.2223-4683.2013.09.0110.3978/j.issn.2223-4683.2013.09.01 ↗
20. 10.1016/j.ccr.2011.05.02610.1016/j.ccr.2011.05.026 ↗
21. 10.1038/nn.378710.1038/nn.3787 ↗
22. 10.1073/pnas.110516010810.1073/pnas.1105160108 ↗
23. 10.1016/j.bbadis.2012.02.00610.1016/j.bbadis.2012.02.006 ↗
24. 10.1002/smll.20080094910.1002/smll.200800949 ↗
25. Gregory · Cancer Research · 2001 · 61 · 2892
26. 10.1016/S0006-3495(03)74725-010.1016/S0006-3495(03)74725-0 ↗
27. 10.1038/nprot.2016.05910.1038/nprot.2016.059 ↗
28. 10.1016/j.biomaterials.2012.11.03410.1016/j.biomaterials.2012.11.034 ↗
29. 10.1002/anie.20110254510.1002/anie.201102545 ↗
30. 10.1039/c2lc40921f10.1039/c2lc40921f ↗